The Price of Time
November 19, 2026
Higher real yields are putting renewed pressure on early-stage biotech, increasing the appeal of China’s pipeline of drugs already in clinical development
12 min read
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View Profile
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
All the latest Medicine Maker articles.
November 17, 2026
Estelle Verger and Nicolas Voisin from Aptar Pharma’s Injectables business discuss component quality, the changing needs of injectable therapies, and what to expect from a component partner.
5 min read
November 17, 2026
Regeneron’s Andres Sirulnik reflects on the experiences that took him from treating leukemia patients to developing medicines – and why following the science still means putting patients first
6 min read
November 17, 2026
Researchers demonstrate how transient modified mRNA therapy can stimulate heart muscle cell proliferation and improve cardiac function following myocardial infarction
2 min read
November 16, 2026
Vector DNA integration was identified near or within the GLI1 oncogene in tumors from two treated patients
2 min read
November 16, 2026
CAR T pioneer John Maher reflects on the value of curiosity, career-defining setbacks, and pursuing unpopular ideas
1 min read
November 13, 2026
Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies
1 min read
November 12, 2026
How next-generation biomarker strategies could improve patient stratification, strengthen clinical trials, and reduce the cost of drug development
5 min read
November 11, 2026
Replacing guidance from 2011, the FDA's updated framework emphasizes potency assurance throughout cell and gene therapy development and manufacturing
2 min read
November 11, 2026
First liver biopsy following in vivo base editing confirms precise correction of the disease-causing mutation in Pi*ZZ AATD patient
2 min read
November 11, 2026
The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network
2 min read
False